Investing
Bristol-Myers, DryShips Drop into Wednesday's 52-Week Low Club
Published:
Last Updated:
January 25, 2017: Here are four stocks trading with relatively heavy volume among 22 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by nearly 2 to 1 and on the Nasdaq advancers led decliners by more than 2 to 1.
Bristol-Myers Squibb Co. (NYSE: BMY) dropped about 0.3% Wednesday, to post a new 52-week low of $48.81 after closing at $48.96 on Tuesday. The stock’s 52-week high is $77.12. Volume was about equal to the daily average of around 11.4 million shares. The company had no specific news Wednesday.
DryShips Inc. (NASDAQ: DRYS) dropped about 8.9% on Wednesday to post a new split-adjusted 52-week low of $4.4.08 against a 52-week high of $278.40 and a Tuesday close of $5.40. Volume of around 10 million was nearly 5 times the daily average of around 2.2million. New shares began trading Tuesday morning after a 1-for-8 reverse stock split that valued the new shares at about $8.00.
The Michaels Companies Inc. (NASDAQ: MIK) dropped about 8.4% Wednesday to post a new 52-week low of $19.95 after closing Tuesday at $21.78. The 52-week high is $31.36. Volume of around 8.3 million was about 5 times the daily average of around 1.8 million shares traded. The company announced a secondary offering after markets closed last night.
Meridian Bioscience Inc. (NASDAQ: VIVO) dropped about 34.5% on Wednesday to post a new 52-week low of $10.77 after closing at $16.45 on Tuesday. Volume was about 10 times the daily average of around 310,000. The company cut its dividend and reported a poor first-fiscal quarter’s results.
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.